Companies /Healthcare

Merck & Co Inc

NYSE: MRK Drug Manufacturers - General
$146.33
▲ $5.40 (+3.83%) today
Markets closed · 8:42pm ET

MRK Coverage Page 76

7:44am ET
Health and Healthcare

Merck’s Guidance A Relief (MRK)

Merck & Co. (NYSE: MRK) has just posted earnings that may be a relief to many who were worried about recent Vytorin woes affecting 2008 numbers.  The company posted EPS of $0.80…

MRK
Douglas A. McIntyre
2:59pm ET
Investing

More DJIA Earnings Pressing (MO, MRK, PG, XOM)

We are over half-way through earnings season now, but we still have four DJIA components set to report earnings this week.  We’ve also provided a link here to see which targets are…

Douglas A. McIntyre
1:15pm ET
Health and Healthcare

Merck (MRK) Losing Out On OTC?

If a company like Merck (MRK) is going to overcome problems with a lot its drugs going "off patent" it is going to have to come up with some new ways to…

MRK
Douglas A. McIntyre
9:32am ET
Investing

Merck (MRK) Estimates Miss Street

Merck (MRK) is not going to do as well as Wall St. had hoped next year. It guided to $3.28 to $3.38 earnings per share. A Reuters poll puts the number at…

MRK
Douglas A. McIntyre
8:29am ET
Investing

Pre-Market Stock News (November 9, 2007)

Allscripts (MDRX) traded down 25% after missing earnings estimates and after lower guidance for 2007 and 2008. American Tower (AMT) replacing Alltel (AT) in S&P. ARM Holdings plc (ARMHY) trading down about…

Douglas A. McIntyre